HPV Testing vs Visual Inspection for Cervical Cancer Screening in Rural China
Author Information
Author(s): Shi Ju-Fang, Canfell Karen, Lew Jie-Bin, Zhao Fang-Hui, Legood Rosa, Ning Yan, Simonella Leonardo, Ma Li, Kang Yoon-Jung, Zhang Yong-Zhen, Smith Megan A, Chen Jun-Feng, Feng Xiang-Xian, Qiao You-Lin
Primary Institution: Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, Peking Union Medical College
Hypothesis
Is primary HPV-DNA testing more effective and cost-effective than visual inspection methods for cervical cancer screening in rural China?
Conclusion
Primary careHPV screening is more effective and cost-effective compared to visual inspection methods for cervical cancer screening in rural China.
Supporting Evidence
- careHPV testing showed high sensitivity for detecting cervical intraepithelial neoplasia.
- Once-lifetime screening at age 35 years could reduce cancer mortality by 12% with careHPV.
- Regular screening could reduce cervical cancer mortality by 43-54% using IARC-recommended intervals.
Takeaway
This study found that using a new HPV test can help find cervical cancer better than older methods, especially in rural areas of China.
Methodology
The study used a dynamic simulation model to assess the cost-effectiveness of careHPV screening compared to visual inspection methods, using data on sexual behavior, test accuracy, and costs.
Potential Biases
Potential overestimation of visual inspection sensitivity due to verification bias.
Limitations
The model is based on assumptions about HPV infection progression and lacks extensive local data on health state preferences.
Participant Demographics
The study involved 662 females aged 15-59 years from rural Shanxi Province.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website